Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature

Patients with sickle cell disease (SCD) suffer from complications due to anemia, inflammation, and vaso-occlusion. Factors that trigger sickling and/or inflammation may initiate such complications, while treatment with hydroxyurea (HU) reduces their emergence and prolongs survival. On the contrary,...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamantopoulos, Panagiotis T, Anastasopoulou, Amalia, Dimopoulou, Maria, Samarkos, Michalis, Gogas, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021083/
https://www.ncbi.nlm.nih.gov/pubmed/36936358
http://dx.doi.org/10.1177/20406207231155991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021083/
https://www.ncbi.nlm.nih.gov/pubmed/36936358
http://dx.doi.org/10.1177/20406207231155991

Ejemplares similares